Next-generation characterization of the Cancer Cell Line Encyclopedia

Large panels of comprehensively characterized human cancer models, including the Cancer Cell Line Encyclopedia (CCLE), have provided a rigorous framework with which to study genetic variants, candidate targets, and small-molecule and biological therapeutics and to identify new marker-driven cancer dependencies. To improve our understanding of the molecular features that contribute to cancer phenotypes, including drug responses, here we have expanded the characterizations of cancer cell lines to include genetic, RNA splicing, DNA methylation, histone H3 modification, microRNA expression and reverse-phase protein array data for 1,072 cell lines from individuals of various lineages and ethnicities. Integration of these data with functional characterizations such as drug-sensitivity, short hairpin RNA knockdown and CRISPR-Cas9 knockout data reveals potential targets for cancer drugs and associated biomarkers. Together, this dataset and an accompanying public data portal provide a resource for the acceleration of cancer research using model cancer cell lines.

1. 1
   limma powers differential expression analyses for RNA-sequencing and microarray studies

   Nucleic Acids Research201542,254 citationsDataRank 1.6
2. 2
   Analysis of protein-coding genetic variation in 60,706 humans

   Nature201610,291 citationsDataRank 15.2Top 12%
3. 3
   From FastQ Data to High‐Confidence Variant Calls: The Genome Analysis Toolkit Best Practices Pipeline

   Current Protocols in Bioinformatics20137,169 citationsDataRank 1.3
4. 4
   Genetic effects on gene expression across human tissues

   Nature20174,625 citationsDataRank 16.3Top 10%
5. 5
   Pan-cancer single-cell RNA-seq identifies recurring programs of cellular heterogeneity

   Nature Genetics2020455 citationsDataRank 0.918